 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $32.146,26 | (29/05/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.910,48 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $12.746,32 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $37.076,16 | (29/05/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $16.119,03 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $12.820,84 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $40.532,83 | (29/05/25) |
| PAMI |
|
| AF $15.230,42 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $15.469,60 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $40.780,32 | (29/05/25) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $25.948,91 | (29/05/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $10.807,67 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $8.189,91 |
|
|
|
|
| |
